Healthcare Market Research Reports & Industry Analysis

Publications found: 73,128
Sort by:

Global Advanced Wound Care Market Outlook 2018

US$ 1,500.00

... stays, resulting in overall reduced costs. A new research study conducted by RNCOS, “Global Advanced Wound Care Market Outlook 2018”, reveals that the ... discusses the various upcoming technologies which will further help in advancing the healing process. Overall, the research contains exhaustive information ...

February 2015 55 pages

Renal Cell Carcinoma: KOL Insight

US$ 7,495.00

... ? Renal Cell Carcinoma: KOL Insight offers opinions of 12 leading US and European KOLs that present business-critical insights for branded pharma and the drug discovery community. Gain insights ... 2 anonymous German KOLs Report Features Insightful drug and development analysis with “real world” opinions of leading US and European KOLs not available elsewhere ...

February 2015 -

The Rise of Wearable Healthcare Technology: Opportunities and Challenges for Pharma

US$ 595.00

... The Rise of Wearable Healthcare Technology: Opportunities and Challenges for Pharma, FirstWord examines an emerging ... line between consumer and healthcare wearables is increasingly blurred—and how pharma can be part of a future in which wearing healthcare technology is the new normal ...

February 2015 -

Trends and Innovations in Lifecycle Management

US$ 595.00

Trends and Innovations in Lifecycle Management (LCM) presents business-critical insights for strategic planners ... and anticipates, rather than reacts to, changes in the market. Trends and Innovations in Lifecycle Management offers unique expert insights into how you can ...

February 2015 -

Global Glucose Monitoring Market Report: 2015 Edition

US$ 800.00

... non-invasive blood glucose monitoring, among others. This report offers a comprehensive analysis of the global glucose monitoring industry. Furthermore, market dynamics such ... are analyzed in depth. On the contention front, the global glucose monitoring market is reined by few major players namely, Johnson and ...

January 2015 54 pages

Physician Views: Let the games begin – Remicade biosimilar free to debut in EU5 markets

US$ 695.00

... versions of more complex pharmaceuticals – such as infliximab – raise key questions of physician sentiment, which will play a key role in shaping adoption and ...

January 2015 -

Physician Views: The hepatitis C pricing war - what impact on prescribers?

US$ 695.00

... move, AbbVie agreed last month to provide its newly approved hepatitis C drug Viekira Pak to Express Scripts at an undisclosed discount in exchange for ... formulary exclusions) are viewed by the doctors, who will play a critical role as all-important prescribers of the medicines. Physician surveys and recently ...

January 2015 -

2015 Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU) Supplier Shares and Sales Forecasts for 300 Tests

US$ 10,000.00

... among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals closer to the patient. Market Segmentation Analysis ... during the next ten years.- Design criteria for POC testing products.- Alternative business expansion strategies.- Potential market entry barriers ...

January 2015 973 pages

Physician Views: Are dermatologists ready for a new class of psoriasis therapies?

US$ 695.00

... profile, at least initially. In the psoriasis setting (the IL-17A inhibitors are being studied across additional indications), the next 12 months could ... class as a whole. In response to EU approval, we are polling EU5 and US-based dermatologists with the following questions… How aware are you of secukinumab? How impressive ...

January 2015 -

Global Rising Stars Outlook 2015: Innovative Therapies for Treating Diseases are Being Sought after with Fresh Vigor as New Targets

US$ 2,000.00

Innovative Therapies for treating diseases ... interested in keeping pace with the development of new medicines. The Regenerative medicine Universe is large and new companies are being ... coverage in our Outlook this year. Key Criteria for Our Selection are:- Uniqueness of the Technology platform and the ability ...

January 2015 72 pages

Physician Views: The FDA gives a thumbs-up to the first potential US biosimilar, but what do oncologists think?

US$ 695.00

... expected. The overwhelmingly positive nature of the AdCom and the FDA's stance towards Zarxio are, nevertheless, highly encouraging. As is the ... PIONEER study). A critical factor in defining the success of biosimilars will be physician sentiment towards these products. Furthermore, this dynamic looks ...

January 2015 -

Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of Pain

US$ 3,000.00

... cyclooxygenase (COX) inhibitors, amine reuptake inhibitors and anticonvulsants, ... acute and chronic moderate to severe pain. Globally, pain is one of the ... formulations can be better understood from FDA’s non-approval of oxycontin generics in 2013. The revised labeling with abuse deterrence has protected Purdue ...

January 2015 65 pages

Neurostimulation: Market Research Report

US$ 4,950.00

This report analyzes the worldwide markets for Neurostimulation in US$ by the following Product Segments: Spinal Cord Stimulators (SCS), Deep ... 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

January 2015 220 pages

Blood Gas and Electrolyte Analyzers: Market Research Report

US$ 4,500.00

... report analyzes the worldwide markets for Blood Gas and Electrolyte Analyzers in Units and US$ Thousand by the following Product Segments: Blood Gas Analyzers (Benchtop Analyzers, & Point-of-Care Analyzers), and Electrolyte Analyzers. The ...

January 2015 321 pages

Predictive Analytics: Market Research Report

US$ 4,500.00

... report analyzes the worldwide markets for Predictive Analytics in US$ by the following Application Segments: Financial & Risk Management, Distribution & CRM, Marketing & Sales, and Personnel & Operations ... . Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company ...

January 2015 354 pages

Metabolic Testing Solutions: Market Research Report

US$ 4,500.00

... the worldwide markets for Metabolic Testing Solutions in US$ Thousand by the following Product Segments: ECGs/EKGs, Metabolic Carts, CPET Systems, and Others. The market is also analyzed ... 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

January 2015 273 pages

Healthcare Cloud Computing: Market Research Report

US$ 4,500.00

This report analyzes the worldwide markets for Healthcare Cloud Computing in US$ Thousand. The Global market is further analyzed by the following Application Segments: Clinical Information Systems ... key and niche players such as - Agfa-Gevaert Group Allscripts Healthcare Solutions, Inc. AT&T Inc. athenahealth, Inc. CareCloud Corporation

January 2015 286 pages

Cell Surface Markers Identification: Market Research Report

US$ 4,500.00

... worldwide markets for Cell Surface Markers Identification in US$ Million by the following Product Segments: Flow Cytometers, and Others. The Global market is further analyzed by the following Application Markets ... 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

January 2015 290 pages

mHealth (Mobile Health) Services: Market Research Report

US$ 4,500.00

This report analyzes the worldwide markets for mHealth (Mobile Health) Services in US$ Million. The report provides separate comprehensive analytics for the US, ... forecasts are provided for the period 2013 through 2020. Market data and analytics are derived from primary and secondary ...

January 2015 275 pages

Huntington's Disease Therapeutics: Market Research Report

US$ 4,500.00

This report analyzes the worldwide markets for Huntington's Disease Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, ... 2020. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

January 2015 122 pages

Intracranial Stents: Market Research Report

US$ 4,950.00

This report analyzes the worldwide markets for Intracranial Stents in US$ Thousands. The report provides separate comprehensive analytics for the US, ... 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

January 2015 94 pages

Global Acne Treatment Market: Trends and Opportunities (2014-2019)

US$ 800.00

... titled “Global Acne Treatment Market: Trends and Opportunities (2014-2019)” provides an insight into the acne market with focus on global prescription drugs. The report assesses the market sizing ... laser treatment for acne, technology driven products are the key trends of the acne industry. However, with immense growth opportunities, the global acne market faces the ...

January 2015 65 pages

Google’s Ambitions in Health

US$ 595.00

... , with $47.3 billion, healthcare funding in 2014 dominated the technology space. In Google's Ambitions in Health, FirstWord maps the journey of one of the leading technology companies ... insights into Apple’s ambitions in the space Assessments of Google’s European and US investments and ventures Expert insight into DIY Health and its future ...

January 2015 -

Therapeutic Class Overview: Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of Pain

US$ 3,000.00

... of novel delivery technologies employed in the formulation of abuse deterrent product, technologies employed in enhancing patient compliances and emerging novel mechanisms in the management of pain. Renewed interest on pain therapy ...

December 2014 64 pages

Physician Views: And then there were two – will AbbVie's 3-DA regimen prove a compelling competitor to Gilead's Harvoni?

US$ 695.00

... be crucial in driving uptake. For example, there remains uncertainty as to whether AbbVie will ... is focused on whether the FDA takes the view that a minimum 95 percent sustained virological response ... -experienced and cirrhotic patients, and whether physicians also use ribavirin in treatment-naive genotype ...

December 2014 -

US Proton Therapy Market Opportunity Analysis

US$ 1,500.00

... Proton Therapy Market Opportunity Analysis” Report Highlight: US Proton Therapy Market Overview Targeted Patient Base & Economic Capacity Analysis Proton Therapy Cost Analysis Proton Therapy Reimbursement Policy Proton Therapy Center Infrastructure Analysis US Proton Therapy Market ...

December 2014 87 pages

Delivering Quality Healthcare to the Digital Home: the 2014 Edition

US$ 3,500.00

... in the Obamacare era and analyzes digital technology’s impact on care quality, access, and cost. It covers four home care business areas ... model innovations, and home care Impact of digital technology on care quality, access, and cost In-depth analysis of the U.S. connected health market ...

December 2014 87 pages

Physician Views: Sanofi's Lemtrada finally approved in the US – how will neurologists use the multiple sclerosis therapy?

US$ 695.00

... market, equal to around 50 percent of all patients, noted Sanofi management last week (ViewPoints: Sanofi's Lemtrada flies the flag for patient power; can ... European physicians is encouraging (a trend supported by a pre-launch Physician Views poll run by FirstWord last year; Physician Views Poll Results – Sanofi's new multiple sclerosis treatment Lemtrada to be used ...

November 2014 -

Trends in Measuring and Rewarding KAM Team Performance

US$ 595.00

... , KAMs build relationships. Trends in Measuring and Rewarding KAM Team Performance provides a unique view of KAM teamwork situations, performance measurements, incentive schemes and the ... only make such measures effective and fair, but improve the whole performance review environment for KAMs? Trends in Measuring and Rewarding KAM Team ...

November 2014 -

Physician Views: What impact will the IMPROVE-IT study have on the treatment landscape?

US$ 695.00

... . The commercial impact on Merck will be limited, ... Physician Views Poll Results: Lack of outcomes data, negative IMPROVE-IT results will ... Will you be encouraged to prescribe ezetimide ahead of PCSK9 inhibitors in difficult-to-treat patients following publication of positive data from the IMPROVE-IT study? What ...

November 2014 -

Medical Tourism Market in India 2014

US$ 950.00

... after order is placed. Netscribes’ latest market research report titled Medical Tourism Market in India 2014 analyses the growth of the market due to the availability of healthcare facilities ...

November 2014 89 pages

Asia Medical Tourism Analysis & Forecast

US$ 2,800.00

... from the year 2004 – 2018 II. Medical Tourism Market (Spending) from the year 2009 – 2018 All the 5 countries in the report ... & China 8. Germany 9. Australia 10. France 11. South Korea 12. Canada 13. East Europe 14. Scandinavia 15. Others South Korea Medical Tourists Arrivals and Spending: (15 Countries ...

November 2014 526 pages

Peptide Therapeutics Pipeline Database: 1-Year Subscription

US$ 1,000.00

Peptide Therapeutics Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary Peptide Therapeutics Pipeline Database provides online access to Peptide Therapeutics on the market and in research & development. The peptide segment database contains about 900 files. Each ...

November 2014 -

Hearing Aids Market in India 2014

US$ 950.00

... days after order is placed. Netscribes’ latest market research report titled Dental Implant Market in India 2014 states that the demand for dental ... tourism is another factor aiding growth in the market since the entire dental implant procedure costs much lesser in India compared to the developed Western ...

November 2014 51 pages

Competitor Analysis: Cardiometabolic Peptides

US$ 500.00

Competitor Analysis: Cardiometabolic Peptides The Competitive Intelligence Report Cardiometabolic Peptides as of November 2014 provides a competitor analysis in the development pipeline of peptide therapeutics for treatment of diabetes, obesity and atherosclerosis. Purchase of the pdf report includes a 6- ...

November 2014 77 pages

Middle East NIPT Market Outlook

US$ 1,400.00

... risk of having a baby suffering from Down’s syndrome increases. This is where NIPT, non-invasive procedures to identify subgroups of mothers who may have a ... are quite prevalent, especially in the Middle East Countries. According to our report “Middle East NIPT Market Outlook”, the aforementioned factors have ...

November 2014 35 pages

Global Hearing Aid Market Report: 2014 Edition

US$ 800.00

... frequencies, certain people have relative insensitivity to sound. Such situation is termed as hearing impairment. The increase in volume above the usual sound levels ... emerged as the two bright spots within the hearing aid market. The report on global hearing aid market contains a comprehensive analysis of the ...

November 2014 82 pages

The US Chronic Pain Market – Focus on Opioids: Trends & Opportunities (2014-19)

US$ 800.00

... US Chronic Pain Therapy Market: Trends & Opportunities (2014-2019)” provides an in-depth analysis of the United States chronic pain therapy market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth and market share of the various ...

November 2014 68 pages

Physician Views: Celgene's mongersen continues to impress in Crohn's – is it too good to be true?

US$ 695.00

There are a handful of reasons why sceptics are incredulous about Celgene's mongersen, this despite – or perhaps even because of – recently unveiled Phase II results ... . See ViewPoints: Expectations heightened for Celgene's Crohn's disease gamble. While there is some theoretical risk mongersen could cause fibrosis by raising TGF ...

October 2014 -

Physician Views: The idiopathic pulmonary fibrosis (IPF) market – let battle commence

US$ 695.00

The battle for market share in the US idiopathic pulmonary fibrosis (IPF) market is one that will be watched with much ...

October 2014 -

Thailand Medical Tourism & Forecast

US$ 1,100.00

... States is standing at the fourth spot in terms of medical tourists visit to Thailand. South Asia, Britain, China and Taiwan are the other top ... ” provides a comprehensive analysis of the Thailand medical tourism market covering in detail various aspects such as medical tourists visits & spending, share of the ...

October 2014 74 pages

Physician Views: Can Movantik revolutionise the opioid-induced constipation market?

US$ 695.00

... AstraZeneca and Nektar Therapeutics' Movantik, the first PAMORA product that is dosed orally (ViewPoints: Is AstraZeneca's motivation key to Movantik's commercial success?). ... daily, oral PAMORA drug indicated for OIC. A more bearish view of the market opportunity is shaped in part by retained concerns around ...

October 2014 -

Competitor Analysis: Anti-Infective Peptides

US$ 446.00

Competitor Analysis: Anti-Infective Peptides The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and ... with the project data to print or export an individual report. Anti-Bacterial Peptides Anti-bacterial peptides are used to treat infectious diseases such ...

October 2014 68 pages

India Medical Tourism & Forecast

US$ 1,400.00

... with 260 Figures and 3 Tables provides a complete analysis of top 63 countries who visited India for medical treatment. All the 63 countries in the report have been studied from 2 viewpoints. I. Medical Tourists Arrivals in India from the year 2009 – 2018 II. Medical Tourism ...

October 2014 248 pages

United States – Pain Management Therapeutics Patients & Market Analysis

US$ 1,100.00

... a comprehensive assessment of the fast–evolving, high–growth of United States Pain Management Therapeutics Sector. This 73 page report with 46 Figures and ... the basis of: I. United States Pain Management Therapeutics Market from the year 2005 – 2018 II. United States Pain Management Patients Population from ...

October 2014 73 pages

KOL Insight: Multiple Sclerosis

US$ 7,495.00

... ? Multiple Sclerosis – Oral therapy takes centre stage is a comprehensive Therapy Trends report packed with knowledgeable opinions and insights of 12 leading US and European KOLs on current ... , MD, is a preeminent MS clinician at the Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Co-Director, Multiple Sclerosis Care Center, Maimonides Medical Center Dr Robert Naismith, MD, Assistant Professor ...

October 2014 -

UAE IVF Treatment Market Outlook 2018

US$ 900.00

... can be prevented. “UAE IVF Treatment Market Outlook 2018” Report Highlights: Current Market Scenario IVF Treatment Market Potential Treatment cycle & Birth Rate Fertility Treatment Loan Facility Regulations for Licensing of Fertilization Centers Medical ...

October 2014 70 pages

US Proton Therapy Outlook: Market Opportunities

US$ 2,000.00

... make it more accessible to patients. According to the “US Proton Therapy Outlook: Market Opportunities”, by RNCOS, the United States will be home to almost 29 such centers ... size and its future condition. After a thorough analysis of the market, RNCOS has deduced various trends, drivers and challenges which ...

October 2014 70 pages

Global Sports Medicine Market Report: 2014 Edition

US$ 800.00

... have also been presented. The report also provides company profiles of the key players in the global sports medicine market along with a discussion of their key ...

September 2014 58 pages

Competitor Analysis: Anti-Inflammatory Peptides

US$ 319.00

Competitor Analysis: Anti-Inflammatory Peptides The present Competitive Intelligence Report about peptides therapeutics provides a competitor evaluation in the field of marketed and new molecules for treatment of inflammatory and autoimmune diseases as of September 2014. Anti-Inflammatory peptides under ...

September 2014 44 pages

Filters

Search

Categories

1,254
193
212
1,214
34
241
217
160
142
64,306
1,332
1,265
2,373
185

Publishers

649
541
179
32
1
1,509
34
239
366
389
103
148
348
3
202
3
6
1,623
487
80
123
208
112
31
1,049
383
23
40
68
513
953
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
1,806
60
1,696
8
7,373
2,206
6,530
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
385
8
3
18
58
913
6
89
12
24
15
1,286
229
128
386
3
74
10
119
227
46
474
26
133
4

Regions

201
97
86
75
74
50
48
42
41
40
36
36
35
31
30
29
28
27
27
26
24
24
18
17
17
17
17
16
16
15
13
12
12
11
10
9
8
8
8
7
7
6
6
6
6
5
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
798
552
2
2
2
118
198
104
61
38
709
75
136
531
215
1,137
66,824

Price

—

Date

—

Pages

—

Offers

1
280
1
1